Back to Journals » ClinicoEconomics and Outcomes Research » Volume 10

An evaluation of the budget impact of a new 20% subcutaneous immunoglobulin (Ig20Gly) for the management of primary immunodeficiency diseases in Switzerland

Total article views   HTML views PDF downloads Totals
9,989 Dovepress* 9,289+ 1,468 10,757
PubMed Central* 700 240 940
Totals 9,989 1,708 11,697
*Since 10 April 2018
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar